Evidence map›Paper›PMID 25980347›Full record

ArticleCell metabolism2015

Diet-induced obese mice retain endogenous leptin action.

Nickki Ottaway, Parinaz Mahbod, Belen Rivero, Lee Ann Norman, Arieh Gertler, David A D'Alessio, Diego Perez-Tilve

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Tanycytes: bloodhounds of the metabolic brain.Trends in endocrinology and metabolism: TEM · 2026
    Review
  5. Article
  6. TonEBP as a key regulator of hypothalamic leptin signaling and resistance.Cellular and molecular life sciences : CMLS · 2026
    Article
  7. Article
  8. Article
  9. Heat-InactivatedInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Review
  12. History and future of leptin: Discovery, regulation and signaling.Metabolism: clinical and experimental · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.Advances in experimental medicine and biology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. LRP1 regulates food intake and energy balance in GABAergic neurons independently of leptin action.American journal of physiology. Endocrinology and metabolism · 2021
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nickki OttawayDepartment of Internal Medicine, Metabolic Diseases Institute, University of Cincinnati, OH 45237, USA.
Parinaz MahbodDepartment of Internal Medicine, Metabolic Diseases Institute, University of Cincinnati, OH 45237, USA.
Belen RiveroDepartment of Internal Medicine, Metabolic Diseases Institute, University of Cincinnati, OH 45237, USA; Department of Pharmacology, University of Granada, Granada 18071, Spain.
Lee Ann NormanDepartment of Internal Medicine, Metabolic Diseases Institute, University of Cincinnati, OH 45237, USA.
Arieh GertlerInstitute of Biochemistry, Food Science, and Nutrition, The Hebrew University of Jerusalem, Rehovot 7610001, Israel.
David A D'AlessioDepartment of Internal Medicine, Metabolic Diseases Institute, University of Cincinnati, OH 45237, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
Diego Perez-TilveDepartment of Internal Medicine, Metabolic Diseases Institute, University of Cincinnati, OH 45237, USA. Electronic address: pereztdo@ucmail.uc.edu.
University of Cincinnati · USDuke University · USHebrew University of Jerusalem · ILUniversidad de Granada · ES

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
The role of GLP-1 in normal and abnormal glucose toleranceR01DK057900 · NIDDK · UNIVERSITY OF CINCINNATI · PI D'ALESSIO, DAVID A. · 1999 to 2013
$3.4M
Short Term Medical Student Training GrantT35DK060444 · NIDDK · UNIVERSITY OF CINCINNATI · PI JASON T BLACKARD · 2002 to 2026
$2.3M
Neuroendocrine Regulation of Adipocyte MetabolismR01DK077975 · NIDDK · UNIVERSITY OF CINCINNATI · PI PEREZ-TILVE, DIEGO · 2009 to 2013
$1.7M
NIDDK NIH HHS DK077975NIDDK NIH HHS DK57900NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK057900NIDDK NIH HHS R01 DK077975NIDDK NIH HHS T35 DK060444
6 · The paper itself

Abstract

Obesity is characterized by hyperleptinemia and decreased response to exogenous leptin. This has been widely attributed to the development of leptin resistance, a state of impaired leptin signaling proposed to contribute to the development and persistence of obesity. To directly determine endogenous leptin activity in obesity, we treated lean and obese mice with a leptin receptor antagonist. The antagonist increased feeding and body weight (BW) in lean mice, but not in obese models of leptin, leptin receptor, or melanocortin-4 receptor deficiency. In contrast, the antagonist increased feeding and BW comparably in lean and diet-induced obese (DIO) mice, an increase associated with decreased hypothalamic expression of Socs3, a primary target of leptin. These findings demonstrate that hyperleptinemic DIO mice retain leptin suppression of feeding comparable to lean mice and counter the view that resistance to endogenous leptin contributes to the persistence of DIO in mice.

Indexed as

AnimalsBody WeightDietHyperlipidemiasLeptinMiceMice, KnockoutMice, ObeseObesityReceptor, Melanocortin, Type 4Receptors, LeptinSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling ProteinsLeptinMC4R protein, mouseReceptor, Melanocortin, Type 4Receptors, LeptinSocs3 protein, mouseSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling Proteins

Identifiers

PMID25980347
PMCPMC4456263
OpenAlexW1619712336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.